Evidence map›Paper›PMID 22100979›Full record

ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2012

NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors.

Nancy Bunin, Trudy Small, Paul Szabolcs, K Scott Baker, Michael A Pulsipher, Troy Torgerson

Open access · hybridAbstract readConference Proceedings
In one paragraph

Article in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  7. Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2017
    Article
  8. Review
  9. Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2016
    Review
  10. Article
  11. Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2013
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Nancy BuninPerelman School of Medicine, University of Pennsylvania, Philadelphia, 19104, USA. buninn@email.chop.edu
Trudy Small
Paul Szabolcs
K Scott Baker
Michael A Pulsipher
Troy Torgerson
Children's Hospital of Pittsburgh · USFred Hutch Cancer Center · USMemorial Sloan Kettering Cancer Center · USSeattle Children's Hospital · USUniversity of Pennsylvania · USUniversity of Utah · US

Funding

Metabolic Syndrome Following Transplant for LeukemiaR01CA112530 · NCI · UNIVERSITY OF MINNESOTA · PI BAKER, KEVIN S · 2006 to 2010
$2.2M
Pediatric Blood and Marrow Transplant ConsortiumU01HL069254 · NHLBI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI PULSIPHER, MICHAEL A · 2001 to 2010
$2.0M
Immune Reconstitution After Cord Blood TransplantationR01HL091749 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KOMANDURI, KRISHNA V., SZABOLCS, PAUL · 2008 to 2011
$1.6M
Graft Engineering and Immunotherapy After Unrelated Cord Blood TransplantationR01CA132110 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SZABOLCS, PAUL · 2007 to 2011
$1.5M
Blood and Marrow Transplant Clinical Trials NetworkU10HL069254 · NHLBI · UNIVERSITY OF UTAH · PI PULSIPHER, MICHAEL A · 2011 to 2016
$839k
Late Effects after Pediatric HSCT: State of the Science, Future DirectionsR13CA159788 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI BAKER, KEVIN S, PULSIPHER, MICHAEL A · 2011 to 2011
$13k
NCI NIH HHS 1R13CA159788-01NCI NIH HHS 5R01 CA132110NCI NIH HHS R01 CA112530NCI NIH HHS R01 CA132110NCI NIH HHS R13 CA159788NHLBI NIH HHS 5R01HL091749NHLBI NIH HHS R01 HL091749NHLBI NIH HHS U01 HL069254NHLBI NIH HHS U01HL069254NHLBI NIH HHS U10 HL069254
6 · The paper itself

Abstract

Defective immune reconstitution is a major barrier to successful hematopoietic cell transplantation (HCT), and has important implications in the pediatric population. There are many factors that affect immune recovery, including stem cell source and graft-versus-host disease (GVHD). Complete assessment of immune recovery, including T and B lymphocyte evaluation, innate immunity, and response to neoantigens, may provide insight as to infection risk and optimal time for immunizations. The increasing use of cord blood grafts requires additional study regarding early reconstitution and impact upon survival. Immunization schedules may require modification based upon stem cell source and immune reconstitution, and this is of particular importance as many children have been incompletely immunized, or not at all, before school entry. Additional studies are needed in children post-HCT to evaluate the impact of differing stem cell sources upon immune reconstitution, infectious risks, and immunization responses.

Indexed as

Fetal BloodGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansImmunologic Deficiency Syndromes

Identifiers

PMID22100979
PMCPMC3253930
OpenAlexW1973621119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.